Results 231 to 240 of about 60,096 (254)

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Nature, 2021
Steven A Kemp, Guido Papa, Rawlings P Datir   +2 more
exaly  

Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK

Nature Medicine, 2021
Koen B Pouwels, Philippa Clare Matthews, Nicole Stoesser   +2 more
exaly  

Variant-surface-glycoprotein phospholipase C

1998
Dietmar Schomburg, Dörte Stephan
openaire   +1 more source

Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant

Nature Medicine, 2022
Yu Gao, Curtis Cai, Alba Grifoni
exaly  

An overview of precision oncology basket and umbrella trials for clinicians

Ca-A Cancer Journal for Clinicians, 2020
Kristian Thorlund, Edward J Mills
exaly  

mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variant

Nature Medicine, 2022
Henning Gruell, Kanika Vanshylla, Pinkus Tober-Lau   +2 more
exaly  

SARS-CoV-2 Omicron variant: recent progress and future perspectives

Signal Transduction and Targeted Therapy, 2022
Lei Zhang, Long Zhang, Fangfang Zhou
exaly  

Regulation of variant surface glycoprotein synthesis in Trypanosoma brucei

Biochemical Society Transactions, 1988
J, Czichos, B, Ehlers, P, Overath
openaire   +2 more sources

Trypanosoma congolense: Surface glycoproteins of two early bloodstream variants

Experimental Parasitology, 1981
Neal L. Rosen, Masahiko Onodera, Peter J. Hotez, Mary S. Bogucki, Brian Elce, Curtis Patton, W.H. Konigsberg, G.A.M. Cross, Frank F. Richards   +8 more
openaire   +2 more sources

Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

Nature Medicine, 2021
Laurence Chu, David C Montefiori, Rolando Pajon   +2 more
exaly